Animal Antibiotics and Antimicrobials Market – By Product, By Animal Type, By Distribution Channel – Global Forecast, 2025 – 2034

Based on the animal type, the animal antibiotics and antimicrobials market is categorized into companion animals and livestock animals. The livestock animals segment accounted for the highest market share of 58.1% in 2024.
 

• The livestock animals’ segment is further categorized into cattle, swine, poultry, fish, and other livestock animals.
   
• The rising consumption of animal-derived products has led to an upsurge in the demand for options related to control and prevention of diseases, and this resulted in a greater need for antibiotics.
   
• Furthermore, rapid urbanization and the changing patterns towards consumption of animal protein have increased the demand for livestock health services.
   
• In addition, continuous advancements in veterinary medicine and government initiatives aimed at strengthening food security boost the livestock animals demand in the market.
   

Based on the mode of delivery, the global animal antibiotics and antimicrobials market is categorized into oral, topical, injections, and other modes of delivery. The oral segment is poised to reach 44.7% by 2034.

• The oral segment popularity was driven by its ease of administration and cost-effectiveness as compared to other delivery systems.
   
• Oral formulations such as tablets, capsules, and medical feed additives are widely preferred for livestock and companion animals due to their convenience in mass treatment and prophylactic usage.
• In addition, the growing adoption of oral antibiotics in livestock farming further propels the growth in segments in the market.
   

Based on the distribution channel, the global animal antibiotics and antimicrobials market is categorized into veterinary hospital pharmacy, retail pharmacy, and e-commerce. The veterinary hospital pharmacy segment is anticipated to witness high growth to reach USD 4 billion by 2034.
 

• Veterinary hospital pharmacies are the primary providers in animal drugs industry.
   
• These pharmacies ensure easy access to high-quality antibiotics and antimicrobials for both companion and livestock animals.
   
• In addition, the increasing number of veterinary hospitals builds trust among pet owners and livestock farmers as they offer professional consultations and treatment plans tailored to their needs, further strengthen the segment position in the market.
   

North America: In 2024, the U.S. held a significant position in the North America animal antibiotics and antimicrobials market and was valued at USD 1.8 billion.
 

• A well-developed system of veterinary medicine exists in the country which, along with widespread pet ownership and a developed livestock industry, has increased the country’s efforts to prevent bacterial infections and zoonotic diseases from spreading.
   
• For instance, according to the American Pet Product Association (APPA), there are an estimated 65 million households in the U.S. that own at least one pet dog. Cats come in second, being owned by 40 million households. This rising trend of pet ownership contributed to heavy investments in pets, including their treatments and care, contributing to bolstering the market demand.
   
• Additionally, the rising investment in animal healthcare along with the increasing number of product registrations and approvals, supports market expansion.
   
• Therefore, the aforementioned factors have collectively witnessed the contribution of U.S. strengthening its position in the market.
   

Europe: Germany is poised to achieve significant growth in the Europe animal antibiotics and antimicrobials market.
 

• The market growth in the country is driven by the rise in pet population, well-established livestock industry, emphasis on animal welfare and growth in regulatory support.
   
• The country’s strong R&D sector catering to animal health issues coupled with growing demand for high quality animal -derived products, has strengthened its veterinary sector.
   
• Therefore, the above-mentioned factors collectively strengthen the country’s position in the market.
   

Asia Pacific: The China animal antibiotics and antimicrobials market is anticipated to witness rapid growth over the next few years.
 

• The robust growth in the country is driven by expanding livestock industry and rising demand for animal-derived products.
   
• Additionally, increasing urbanization and population growth are propelling meat consumption, which has created the need for essential disease management options, thereby fueling the market demand.
   
• Further, growing advancements in animal healthcare coupled with growing awareness in AMR has stimulated the market growth.
   

Latin America: Brazil's animal antibiotics and antimicrobials market is projected to witness growth in coming years.
 

• The country’s robust livestock industry and focus on productivity enhancement signified its robust growth in the market.
   
• In addition, the growing demand for farm-produced products such as dairy products, meat and milk further amplifies the demand for effective disease management measures.
   
• Furthermore, growing government initiatives to improve animal healthcare and regulatory support catering animal disease management strengthen the country’s position in the market.
   

Middle East and Africa: Saudi Arabia’s animal antibiotics and antimicrobials market is poised to grow at a considerable growth rate in Middle East and Africa market.
 

• The substantial growth in Saudi Arabia market is driven by the country’s expanding livestock farming and spurring demand for animal-derived products.
   
• In addition, the increasing focus on improving animal health to meet the food safety standards coupled with growing awareness for preventive measures tackling zoonotic diseases, are the key contributors to country’s growth.
   
• Furthermore, country’s robust infrastructure positions it as a prominent player in the Middle East and African region.
   

Animal Antibiotics and Antimicrobials Market Share

The market is highly competitive, with several key companies striving to develop novel formulations in the market. This sector also includes established pharmaceutical companies, specialized veterinary medicine manufacturers, and start-up players tackling animal health related issues and adapting to evolving animal health needs. Key participants of the industry such as Zoetis, Boehringer Ingelheim, Elanco Animal Health, Merck & Co., and Virbac are striving to grow and capture the substantial share in the industry and competing for the market share in the industry.
 

Zoetis is one of the leaders in Animal Health offers an extensive range of animal drugs, including antibiotics, vaccines, and diagnostic tools for both livestock and companion animals. Companies invest in R&D for novel treatment solutions addressing the AMR burden, which further enhances their positions within the competitive sector. Further, Elanco and Merck & Co. hold strong positions in the market, providing various animal antibiotics and antimicrobial products, especially for livestock animals. These companies are engaging in new strategic activities like mergers and acquisitions or market collaborations to increase their market presence internationally and enhance sales. For instance, Elanco took over the Animal Health division of Bayer, greatly enhancing the product offerings of Elanco's business in animal health.
 

Animal Antibiotics and Antimicrobials Market Companies

Few of the prominent players operating in the animal antibiotics and antimicrobials industry include:

• AdvaCare Pharma
• Boehringer Ingelheim International
• Ceva
• Dechra
• Meiji Holdings
• Merck & Co.
• Vetoquinol
• Virbac
• Zoetis
• Zovixpharma
   
• Boehringer Ingelheim International leads with innovative solutions in animal health, focusing on addressing the AMR challenges through continuous investment, partnerships, and research collaborations. The company prioritizes sustainable innovation in veterinary medicine and AMR mitigation by investing USD 1 billion per year into R&D, including the development of stewardship programs.
   
• Merck has dedicated significant R&D attention to developing a strong portfolio of antibiotics for animals. Their focus is on creating new vaccine and antibiotic classes, especially for infections such as Salmonella and E-Coli in livestock. Merck also shows their commitment to modern pet medicine with NexGard.
   
• Zoetis provides livestock and pets with effective antibiotics and antimicrobials. They also focus on animal health improvement, with innovations like Simparica for flea and tick control, which helps in the responsible reduction of antimicrobial resistance.
   

Animal Antibiotics and Antimicrobials Industry News

• In April 2024, Elanco received the U.S. Food and Drug Administration (FDA) approval for Pradalex injection for the treatment of respiratory diseases in cattle and swine. Pradofloxacin is a veterinary essential fluoroquinolone antimicrobial that can be given only as a single dose and only by a registered veterinarian within the U.S. Pradalex injection is used within certain age and class of cattle for treatment of BRD, and in swine for the treatment of swine respiratory disease (SRD). This product launch signified expansion in product offering by introduction of a novel treatment catering to the global burden of respiratory diseases among cattle and swine.
   
• In February 2024, Blacksmith Medicines and Zoetis signed a collaboration agreement to develop new antibiotics for animal health. This strategic collaboration aims to develop new antibiotics that will specifically target bacteria addressing animal health issues.
   
• In November 2022, the Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched to address the threats of Antimicrobial Resistance across the globe. The Quadripartite consisting of FAO, UNEP, WHO, and WOAH collaboratively formed an initiative highlighting AMR threat to human and animal health, agriculture, and environment. The platform launch aimed to increase visibility and focus on combating AMR.
   

The animal antibiotics and antimicrobials market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Penicillins
• Tetracyclines
• Sulfonamides
• Macrolides
• Aminoglycosides
• Lincosamides
• Fluoroquinolones
• Cephalosporins
• Other antibiotics and antimicrobial products

Market, By Animal Type

• Companion animals
  • Dogs
  • Cats
  • Horses
  • Other companion animals
• Livestock animals
  • Cattle
  • Swine
  • Poultry
  • Fish
  • Other livestock animals

Market, By Mode of Delivery

• Oral
• Topical
• Injections
• Other modes of delivery

Market, By Distribution Channel

• Veterinary hospital pharmacy
• Retail pharmacy
• E-commerce

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE